Researchers in the Children’s Oncology Group (COG) at Children’s Hospital of Philadelphia (CHOP) are highlighting key factors influencing survival rates after the first relapse of acute lymphoblastic leukemia (ALL) in children. The study, which is the largest of its kind to evaluate leukemia relapse in children, was published recently in the journal Leukemia.

On Friday, September 13, Children's Hospital of Philadelphia (CHOP) and The Wawa Foundation hosted their first Helping Hands Community Care Challenge.

Children’s Hospital of Philadelphia (CHOP) and Advocare announced an affiliation agreement to advance exceptional pediatric care, health outcomes and overall wellness in the communities they serve.

Children's Hospital of Philadelphia and Clínica Alemana de Santiago in Chile celebrated an outstanding 22 years of institutional relationship and professional development.

A study from CHOP’s HI Center provides insights into how to best care for children with Kabuki syndrome and hyperinsulinism.

Facemasks accounted for over half of the top 10% of head impacts experienced by players in the study, highlighting the importance of prioritizing new helmet designs

Researchers from Children’s Hospital of Philadelphia (CHOP) announced findings from a new study that show outpatient diuretic use is common in children with bronchopulmonary dysplasia (BPD), and that factors such as gestational age, severity of BPD, and type of diuretic significantly influenced the timing of medication weaning. The study was published recently in Pediatric Pulmonology.

The ex vivo gene therapy improved sulfatase production and reduced symptoms associated with the disease in preclinical models

Researchers at CHOP announced the results of a new study offering insights into the development of next-generation gene therapies to treat hemophilia A.

Dr. Adam Wolpaw and Dr. Timothy Spear of Children's Hospital of Philadelphia (CHOP) received the Scholar Hope Award and Young Investigator Award respectively from Hyundai Hope On Wheels.